Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
Historik

Vælg chat via ovenstående menu
Luk reklame

DANMARKS STØRSTE INVESTORSITE MED DEBAT, CHAT OG NYHEDER

bluebird bio FDA priority review


98756 tommycarstensen 22/11 2021 14:31
Oversigt

Den her er ogsaa interessant ifm Novo Nordisk, fordi bluebird og Novo har et haemofili-forskningssamarbejde. Bluebird bio stiger 10% i pre market.

bluebird bio Announces FDA Priority Review of Biologics License Application for beti-cel Gene Therapy for Patients with β-thalassemia Who Require Regular Red Blood Cell Transfusions
https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-announces-fda-priority-review-biologics-license

bluebird bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases
https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-and-novo-nordisk-enter-research-agreement-develop



TRÅDOVERSIGT